Vascular Closure Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers Global Vascular Closure Devices Market Outlook and Manufacturers and it is Segmented by Product Type (Active Approximators and Passive Approximators), Mode of Access (Femoral Access and Radial Access), End Users (Hospitals, Ambulatory Surgical Centers, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The report offers the value (in USD million) for the above segments.

Vascular Closure Devices Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Vascular Closure Devices Industry Overview

This market is expected to witness lucrative growth due to a high level of competitive rivalry, which translates to high revenue generation in this sector. The prominent players in this market are involved in developing novel VCDs and, in turn, broadening their product portfolios. Acquisition and collaboration with small companies to enhance presence are also expected to propel growth in this vertical. The major players in the market are Abbott Laboratories, Cardinal Health Inc., Biotronik SE & Co. KG, Cardinal Health Inc., CardivaMedical Inc., and Terumo Corporation.

Vascular Closure Devices Market Leaders

  1. Cardinal Health

  2. Abbott Laboratories

  3. Cardiva Medical Inc.

  4. Terumo Corporation

  5. Biotronik SE & Co. KG

  6. *Disclaimer: Major Players sorted in no particular order
Vascular Closure Device Market Concentration

Vascular Closure Devices Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?